Francoise Durrieu

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.

Journal: International journal of environmental research and public health

Published: March 29, 2023

Evaluation of the WBC-differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institution.

Evaluation of the WBC-differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institution.

Journal: International journal of laboratory hematology

Published: May 20, 2022

Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.

Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.

Journal: Cancer medicine

Published: March 01, 2021

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.

Journal: Cancers

Published: August 05, 2020

A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.

A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.

Journal: British journal of haematology

Published: November 29, 2019

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Journal: Cancer medicine

Published: June 07, 2019

Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells.

Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells.

Journal: Cancers

Published: January 11, 2019

Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry.

Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry.

Journal: Annales de biologie clinique

Published: December 14, 2018

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.

Journal: BMC cancer

Published: October 03, 2018

Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow Cytometry.

Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow Cytometry.

Journal: Cytometry. Part B, Clinical cytometry

Published: July 27, 2018

CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.

CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.

Journal: British journal of haematology

Published: May 19, 2018

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor.

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 01, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026